1
Camellia W Adams, Andrew C Chan, Craig W Crowley, Henry B Lowman, Gerald R Nakamura, Leonard G Presta: Immunoglobulin variants and uses thereof. Genentech, Morrison & Foerster, September 21, 2010: US07799900 (39 worldwide citation)

The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.


2
Phillip W Berman, Gerald R Nakamura: HIV envelopolype peptides. Genentech, Emily M Haliday, Quine Intellectual Property Law Group P C, October 19, 2004: US06806055 (35 worldwide citation)

A method for the rational design and preparation of vaccines based on HIV envelope polypeptides is described. In one embodiment, the method for making an HIV gp120 subunit vaccine for a geographic region comprises determining neutralizing epitopes in the V2 and/or C4 domains of gp120 of HIV isolates ...


3
Camellia W Adams, Andrew C Chan, Craig W Crowley, Henry B Lowman, Gerald R Nakamura, Leonard G Presta: Immunoglobulin variants and uses thereof. Genentech, Morrison & Foerster, October 22, 2013: US08562992 (33 worldwide citation)

The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.


4
Phillip W Berman, Gerald R Nakamura: HIV envelope polypeptides. Genentech, Emily M Haliday, Suzanne Mack, McCutchen Doyle Brown & Enersen, March 28, 2000: US06042836 (26 worldwide citation)

A method for the rational design and preparation of vaccines based on HIV envelope polypeptides is described. In one embodiment, the method for making an HIV gp120 subunit vaccine for a geographic region comprises determining neutralizing epitopes in the V2 and/or C4 domains of gp120 of HIV isolates ...


5
Phillip W Berman, Gerald R Nakamura: HIV envelope polypeptides. Genentech, Emily M Haliday, The Law Offices of Jonathan Alan Quine, December 18, 2001: US06331404 (15 worldwide citation)

A method for the rational design and preparation of vaccines based on HIV envelope polypeptides is described. In one embodiment, the method for making an HIV gp120 subunit vaccine for a geographic region comprises determining neutralizing epitopes in the V2 and/or C4 domains of gp120 of HIV isolates ...


6
Phillip W Berman, Gerald R Nakamura: HIV envelope polypeptides. Genentech, Laura Terlizzi, Emily M Haliday, McCutchen Doyle Brown & Enersen, January 26, 1999: US05864027 (7 worldwide citation)

A method for the rational design and preparation of vaccines based on HIV envelope polypeptides is described. In one embodiment, the method for making an HIV gp120 subunit vaccine for a geographic region comprises determining neutralizing epitopes in the V2 and/or C4 domains of gp120 of HIV as depic ...


7
Henry B Lowman, Gerald R Nakamura, Mark E Reynolds, Melissa A Starovasnik: IgE receptor antagonists. Genentech, Craig G Svoboda, September 5, 2006: US07101851 (2 worldwide citation)

The invention provides novel compounds which bind to the high affinity receptor for immunoglobulin E (IgE) designated FcεRI and methods for identifying and preparing such compounds. In particular aspects, the invention provides to the treatment of disorders mediated by IgE utilizing the novel compou ...


8

9
Saloumeh Fischer, Dana L Baker, Henry B Lowman, Gerald R Nakamura: Assays for detecting antibodies specific to therapeutic anti-IgE antibodies and their use in anaphylaxis. Genentech, Morrison & Foerster, April 19, 2016: US09315583

The invention provides methods and reagents useful for detecting anti-drug antibodies of IgE isotype to therapeutic anti-IgE antibodies, and methods for assessing risk of anaphylaxis to administration of a therapeutic anti-IgE antibody.


10
Min Xu, Mercedesz Balazs, Ning Chai, Nancy Chiang, Henry Chiu, Zhonghua Lin, Patrick Lupardus, Gerald R Nakamura, Hyunjoo Park, Lee Swern: Anti-hemagglutinin antibodies and methods of use. Genentech, James E Nesbitt, June 30, 2015: US09067979

The present invention provides anti-hemagglutinin antibodies, compositions comprising anti-hemagglutinin antibodies, and methods of using the same.